top of page
MISAA/TacAssay
Login to favorite a company
Creating a 15-min blood test for tacrolimus, crucial for organ transplant patients
Most Recent Valuation:
$10,000,000.00
Legal Name:
Founded:
State of HQ:
MISAA, LLC
07/24/2023
CALIFORNIA
Company Description
Employees:
[]
Funding Summary
Number of funding rounds
1
Total amount raised
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
MISAA/TaceAssay Class B Unit 1 | $13,158.00 | open | Common Stock | $99 | $10,000,000 | 1 |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|---|---|---|
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|---|---|---|---|
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page